acridines has been researched along with Bone Marrow Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, RA; Glaubiger, D; Gormley, P; Howser, K; Levine, AS; Von Hoff, DD; Young, RC | 1 |
| Gürtler-Krawczyńska, E; Topolska, P | 1 |
1 trial(s) available for acridines and Bone Marrow Diseases
| Article | Year |
|---|---|
Phase I study of methanesulfonamide, N-[4-(9-acridinylamino)-3-methoxyphenyl]-(m-AMSA) using a single-dose schedule.
Topics: Acridines; Adolescent; Adult; Antineoplastic Agents; Bone Marrow Diseases; Child; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Phenylenediamines | 1978 |
1 other study(ies) available for acridines and Bone Marrow Diseases
| Article | Year |
|---|---|
Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes.
Topics: Acridines; Anemia, Hemolytic; Bone Marrow Diseases; Bone Marrow Examination; Color; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Lymph Nodes; Methods; Microscopy, Fluorescence; Multiple Myeloma; Myeloproliferative Disorders; Primary Myelofibrosis; Spleen | 1968 |